Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia
Authors
Keywords
Human papillomavirus, Cytology, Vaccination and immunization, Cancer screening, Cervical cancer, Human papillomavirus infection, Cost-effectiveness analysis, Cancer treatment
Journal
PLoS One
Volume 12, Issue 1, Pages e0163509
Publisher
Public Library of Science (PLoS)
Online
2017-01-18
DOI
10.1371/journal.pone.0163509
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use
- (2016) Megan A. Smith et al. BMC HEALTH SERVICES RESEARCH
- The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000-2011)
- (2016) Lisa J. Whop et al. CANCER
- The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples
- (2016) Renée M.F. Ebisch et al. INTERNATIONAL JOURNAL OF CANCER
- Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries
- (2016) Kate T. Simms et al. INTERNATIONAL JOURNAL OF CANCER
- HPV vaccine impact in Australian women: ready for an HPV-based screening program
- (2016) Julia ML Brotherton et al. MEDICAL JOURNAL OF AUSTRALIA
- Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand
- (2016) Jie-Bin Lew et al. PLoS One
- Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
- (2015) Mélanie Drolet et al. LANCET INFECTIOUS DISEASES
- Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program
- (2015) Sarah L. Osborne et al. VACCINE
- HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis
- (2014) L Rodríguez-Carunchio et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds
- (2014) Henry C Kitchener et al. HEALTH TECHNOLOGY ASSESSMENT
- Fall in Genital Warts Diagnoses in the General and Indigenous Australian Population Following Implementation of a National Human Papillomavirus Vaccination Program: Analysis of Routinely Collected National Hospital Data
- (2014) Megan A. Smith et al. JOURNAL OF INFECTIOUS DISEASES
- Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
- (2014) Sepehr N Tabrizi et al. LANCET INFECTIOUS DISEASES
- Cervical screening rates for women vaccinated against human papillomavirus
- (2014) Alison C Budd et al. MEDICAL JOURNAL OF AUSTRALIA
- Decreased Management of Genital Warts in Young Women in Australian General Practice Post Introduction of National HPV Vaccination Program: Results from a Nationally Representative Cross-Sectional General Practice Study
- (2014) Christopher Harrison et al. PLoS One
- Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand
- (2013) Leonardo M Simonella et al. BMC INFECTIOUS DISEASES
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
- (2013) Guglielmo Ronco et al. LANCET
- Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: Independent estimates from a nationally representative mobile phone survey
- (2013) Julia M.L. Brotherton et al. VACCINE
- Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data
- (2013) H. Ali et al. BMJ-British Medical Journal
- Cervical cancer screening in Middle Eastern and Asian migrants to Australia: A record linkage study
- (2012) Nayyereh Aminisani et al. Cancer Epidemiology
- Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance
- (2012) Julia ML Brotherton et al. Future Microbiology
- Clinical Human Papillomavirus Detection Forecasts Cervical Cancer Risk in Women Over 18 Years of Follow-Up
- (2012) Philip E. Castle et al. JOURNAL OF CLINICAL ONCOLOGY
- Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
- (2012) Marc Arbyn et al. VACCINE
- Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study
- (2012) R. Legood et al. BMJ-British Medical Journal
- Pilot study will assess whether HPV test should replace smears to screen for cervical cancer
- (2012) J. Wise BMJ-British Medical Journal
- Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study
- (2011) Ju-Fang Shi et al. BMC CANCER
- HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3
- (2011) L. Baandrup et al. GYNECOLOGIC ONCOLOGY
- Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
- (2011) Philip E Castle et al. LANCET ONCOLOGY
- The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia
- (2011) Megan A. Smith et al. VACCINE
- Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies
- (2011) Karen Canfell et al. VACCINE
- Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years
- (2010) Prudence Creighton et al. BMC PUBLIC HEALTH
- Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England
- (2010) R Howell-Jones et al. BRITISH JOURNAL OF CANCER
- Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
- (2010) S. K. Kjaer et al. JNCI-Journal of the National Cancer Institute
- Liquid Compared With Conventional Cervical Cytology
- (2010) Marc Arbyn et al. OBSTETRICS AND GYNECOLOGY
- The predicted impact of vaccination on human papillomavirus infections in Australia
- (2008) Megan A. Smith et al. INTERNATIONAL JOURNAL OF CANCER
- Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination
- (2008) J. D. Goldhaber-Fiebert et al. JNCI-Journal of the National Cancer Institute
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started